Skip to main content
[Preprint]. 2024 Nov 4:2024.10.31.621311. [Version 1] doi: 10.1101/2024.10.31.621311

Table 1:

Matched features of tumors that recurred (cases) vs. non-recurrent tumors (controls)

Variable Categories Case (n=50) Control (n=50*) P-value

Overall pathologic stage Stage I 25 25 1.000
Stage II 25 25

Pathologic T-stage pT0 1 0 .483
pT1 11 15
pT2 32 28
pT3 6 7

Pathologic N-stage pN0 5 5 .977
pN1 26 27
pN2 19 18

Treatment Surgery 4 4 1.000
Surgery + RT 19 19
Surgery + CRT 27 27

Systemic agent Cisplatin 21 23 .848
Cetuximab 5 3
Carboplatin/Taxol 1 1

Smoking history ≤10 pack-years 34 33 .832
>10 pack-years 16 17

RT=radiation therapy, CRT=chemoradiation, P-values are from Fisher-exact test. Freeman-Holton extension was used for more than two categories.

*

Comparison includes duplication of one control as a match for two cases